[
  {
    "ts": "2025-05-02T17:57:01+00:00",
    "headline": "Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients",
    "summary": "Edwards Lifesciences (NYSE:EW) recently celebrated the FDA approval of its SAPIEN 3 TAVR therapy for asymptomatic aortic stenosis patients, a significant development in cardiac care. This milestone, coupled with robust Q1 earnings and updated financial guidance, likely bolstered investors' confidence, contributing to a 5% share price increase over the past month. The company’s advancements align with broader market trends, marked by a 2% rise, driven by strong earnings and positive economic...",
    "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-receives-175701449.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b407f710-c518-3b64-b40c-71e38e6aae17",
      "content": {
        "id": "b407f710-c518-3b64-b40c-71e38e6aae17",
        "contentType": "STORY",
        "title": "Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients",
        "description": "",
        "summary": "Edwards Lifesciences (NYSE:EW) recently celebrated the FDA approval of its SAPIEN 3 TAVR therapy for asymptomatic aortic stenosis patients, a significant development in cardiac care. This milestone, coupled with robust Q1 earnings and updated financial guidance, likely bolstered investors' confidence, contributing to a 5% share price increase over the past month. The company’s advancements align with broader market trends, marked by a 2% rise, driven by strong earnings and positive economic...",
        "pubDate": "2025-05-02T17:57:01Z",
        "displayTime": "2025-05-02T17:57:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vLi2clQ39cq4H4GDgg1AAA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hLmZY7hCIZ66l74wpB8KIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-receives-175701449.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-lifesciences-nyse-ew-receives-175701449.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]